App-Quantinova.ai

Unusual Cause of Fracture

Paul MacMullan - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Indomethacin

Participant Recruitment for Rural RA Care Delivery Model Trial

Bindu Nair - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Albert

Development and Usability Testing of ANSWER-2: A Web-Based Decision Aid for Patients with Rheumatoid Arthritis Considering Biologic Therapy

Jenny Leese - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

The Burden of Gout in Ontario, Canada: A Study of Healthcare Resource Utilization in a Canadian Public Payer Context

Cory Cowan - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Gout

N/A

Solid-phase, ELISA-based and Indirect Immunofluorescence Assays: Is the Gold Standard Worth its Weight in Gold?

Irvin Bromberg - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Carbenoxolone sodium

"Disease Severity and Glucocorticoids Reduction in Systemic Lupus Erythematosus (SLE) Patients Receiving Belimumab in Clinical Practice Settings: Results from OBSErve Study in Canada"

Amyn Sayani - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Glucocorticoid

Process Evaluation of Employment & Arthritis: Making it Work, An Online Program to Help People with Inflammatory Arthritis Maintain Employment

Seah X - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Does Renin-angiotensin System Blockage Protect Lupus Nephritis Patients from Atherosclerotic Cardiovascular Events? A Case-control Study

Dafna Gladman - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Peripheral artery disease

Angiotensin II

Initial Risk Factor Profile and Long-term Cardiovascular Outcome and Mortality in Women with Systemic Lupus Erythematosus. A Prospective Study

Dafna Gladman - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Regional Variability of Minimal Disease Activity among Psoriatic Arthritis Patients in Canada: An Analysis from the Prospective, Observational Registry, BioTRAC

Dalton Sholter - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

Infliximab

Patterns of Biologics Use among Women with Autoimmune Disease Before, During, and After Pregnancy: A Population-based Study

Larry Lynd - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Certolizumab pegol

What Proportion of Patients with PsA Fail to Achieve MDA Based on Patient Reported Outcomes? An Analysis from a Prospective, Observational Registry

Antonio Avina-Zubieta - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

Infliximab

Teaching Appropriate and High Value Rheumatology Care through Simulation: Virtual Interactive Cases

Gordon Tait - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

Methadone hydrochloride

Systematic Review on the Evidence of Pharmacological Treatments Intended to Improve or Slow Progression of Connective Tissue Disease Associated Interstitial Lung Disease

Christopher Ryerson - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Survival of Etanercept (ETN) Responders after Methotrexate (MTX) Failure when ETN is Initiated as Mono or Combination Therapy or ETN Mono Therapy after MTX Withdrawal from ETN/MTX Combination in Long Standing Rheumatoid Arthritis (RA). A Single Center

Sabri Alsaeedi - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

"Recurrence of Scleroderma Renal Crisis in Transplanted Kidney Leading to Graft Failure"

Nader Khalidi - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Microvascular complications of diabetes 1

Amlodipine

Back Pain in Psoriatic Arthritis: Defining Prevalence, Characteristics and Performance of the Different Inflammatory Back Pain Criteria in a Large Psoriatic Arthritis Cohort

Suzanne Li - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Psoriatic arthritis

EMD-66800

The Utility of Serology in Predicting Outcome of Renal Transplantation in Lupus Patients: In a Large Lupus Cohort and Systematic Review

Jorge Medina-Rosas - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Predictors of Response in Patients with Ankylosing Spondylitis Treated with Infliximab or Golimumab in a Real-World Setting

Suneil Kapur - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

Infliximab

Not Your Typical Atypical Case: Scleroderma Renal Crisis and ANCA Associated Glomerulonephritis in Overlap Syndrome

Nadil Zeiadin - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

ANCA-associated glomerulonephritis

Imuran CR

Filters

28841 Abstracts